HomeREVBW • NASDAQ
add
Revelation Biosciences Inc
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.75M | -24.59% |
Net income | -1.73M | 21.66% |
Net profit margin | — | — |
Earnings per share | -4.98 | 99.13% |
EBITDA | -1.75M | 24.70% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.50M | -45.80% |
Total assets | 6.62M | -45.78% |
Total liabilities | 1.91M | -65.61% |
Total equity | 4.71M | — |
Shares outstanding | 905.23K | — |
Price to book | 0.00 | — |
Return on assets | -65.63% | — |
Return on capital | -118.79% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -1.73M | 21.66% |
Cash from operations | -3.75M | -87.12% |
Cash from investing | 17.69K | — |
Cash from financing | 3.69M | — |
Net change in cash | -42.03K | 97.90% |
Free cash flow | -3.29M | -162.78% |
About
Founded
2019
Website
Employees
8
